Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
- Posted on June 8, 2026
- By CNBC
- 0 Views
- 1 min read
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.